Bio-Rad Laboratories Class B
BIO.B
8 hedge funds and large institutions have $2.75M invested in Bio-Rad Laboratories Class B in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
14% more funds holding
Funds holding: 7 → 8 (+1)
0.01% more ownership
Funds ownership: 0.1% → 0.11% (+0.01%)
4% less capital invested
Capital invested by funds: $2.88M → $2.75M (-$129K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BSW
Buckingham Strategic Wealth
Clayton,
Missouri
|
+$406K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$216K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$65.1K |
| 4 |
Renaissance Technologies
New York
|
+$53.4K |
| 5 |
Morgan Stanley
New York
|
+$17.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LW
Libra Wealth
Los Gatos,
California
|
-$282K |
| 2 |
GAM
Gemmer Asset Management
Walnut Creek,
California
|
-$156K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$534 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $990K | +$53.4K | +100 | +5% |
|
|
CL
2
CSS LLC
Chicago,
Illinois
| $715K | – | – | – |
|
|
BSW
3
Buckingham Strategic Wealth
Clayton,
Missouri
| $375K | +$406K | +760 | New |
|
|
4
Morgan Stanley
New York
| $358K | +$17.1K | +32 | +5% |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $200K | +$216K | +405 | New |
|
|
6
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $60K | +$65.1K | +122 | New |
|
7
Wells Fargo
San Francisco,
California
| $26K | – | – | – |
|
|
8
Osaic Holdings
Scottsdale,
Arizona
| $25K | -$534 | -1 | -2% |
|
|
LW
9
Libra Wealth
Los Gatos,
California
| – | -$282K | -500 | Closed |
|
|
GAM
10
Gemmer Asset Management
Walnut Creek,
California
| – | -$156K | -279 | Closed |
|
BIO.B Hedge Fund Activity: Q2 2022 in Review
8 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q2 2022, worth a combined $2.75M — down 4.5% from $2.88M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BIO.B positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Buckingham Strategic Wealth, opening a new position worth an estimated $406K. The largest seller was Libra Wealth, exiting entirely with an estimated $282K sold.
- 8 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q2 2022, up from 7 in Q1 2022.
- Funds reported $2.75M of Bio-Rad Laboratories Class B stock for Q2 2022, down 4.5% quarter-over-quarter.
- 3 funds opened new Bio-Rad Laboratories Class B positions in Q2 2022 and 2 closed out, a net change of +1 holder.
- The largest Bio-Rad Laboratories Class B buyer in Q2 2022 was Buckingham Strategic Wealth, an estimated $406K added.
- The largest Bio-Rad Laboratories Class B seller in Q2 2022 was Libra Wealth, an estimated $282K sold.
Based on aggregated 13F filings for Q2 2022.